Interview, Fireside Chat
Virginie Morgon, CEO of Eurazeo
- Private equity deal flow and aggressive investment behavior are expected to gain momentum by June and July as normal life resumes.
- The S&P 500 index is forecast to be higher one year from the present, reflecting an optimistic market outlook.
- Relocalization of pharmaceutical API production in continental Europe, specifically Germany and France, is predicted to become a major trend.
- The digitalization of the entire payments value chain is anticipated to remain a high-growth and accelerating sector.
- The organization is currently expanding its healthcare portfolio to include both health technology and physical businesses.
- The "O plus" program, a 10-year strategy spanning 2020 to 2030, aims to extend social welfare benefits to all employees and talent across portfolio companies.
- Gender, social, and racial representation across all portfolio company layers will be increased as part of the 2020-2030 strategic plan.
- Eurasio and its portfolio companies have committed to achieving zero net carbon emissions by 2040.
- Investment philosophy emphasizes a long-term "marathon" approach, requiring team members to balance intellectual and emotional intelligence to avoid strategic errors.
- Current market conditions are characterized as neither as dire as feared nor as positive as hoped.